Author

Marie-Christine Bakker

Observed names: M E Bakker, M. Bakker, Marie-Christine E. Bakker, Marie‐Christine E. Bakker

Institution: University Medical Center Utrecht

Observed institutions: Utrecht University, University Medical Center Utrecht, Princess Máxima Center

OpenAlex ID: A5090945641

Can biomarkers be used to improve diagnosis and prediction of metabolic syndrome in childhood cancer survivors? A systematic review

2021 · Vincent G. Pluimakers, Selveta S. van Santen, et al. · Obesity Reviews · 19

Perspectives on follow-up care and research for childhood cancer survivors: results from an international SIOP meet-the-expert questionnaire in Kyoto, 2018

2021 · M E Bakker, V G Pluimakers, et al. · Japanese Journal of Clinical Oncology · 5

Combined prognostic value of post-surgery circulating tumor DNA and tumor-stroma ratio in patients with stage III colon cancer treated with adjuvant chemotherapy.

2025 · Ingrid Franken, Floor Heilijgers, et al. · Journal of Clinical Oncology · 3

Follicle-Stimulating Hormone Receptor Expression and Its Potential Application for Theranostics in Subtypes of Ovarian Tumors: A Systematic Review

2024 · Marie-Christine E. Bakker, Geertruid J. Brink, et al. · Cancers · 3

Therapeutic Strategies Targeting the Tumor–Stromal Microenvironment in Colorectal Cancer: A Narrative Review

2026 · Floor Heilijgers, Marie-Christine Bakker, et al. · Targeted Oncology · 2

Complementary value of a digital pathology biomarker to post-surgery circulating tumor DNA in risk stratification of stage III colon cancer patients receiving adjuvant chemotherapy.

2025 · Ingrid Franken, Marie-Christine Bakker, et al. · Journal of Clinical Oncology · 1

P518: Pedal/eupal International Collaboration to Improve the Outcome of Children With Relapsed or Refractory Acute Myeloid Leukemia

2022 · V. Ceolin, S. Ishimaru, et al. · HemaSphere · 1

Works count: 7

Citation count: 34

H-index: 3

I10-index: 1